Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mitchel Sayare currently holds 34,900 shares of Altimmune, Inc. (ALT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mitchel Sayare has been a net seller of ALT stock. They have purchased $171.7K and sold $4.3M worth of shares.
Mitchel Sayare's most recent insider trade was on Sep 26, 2024, when they sold 34,900 shares at $0.00 per share.
Mitchel Sayare serves as Executive at Altimmune, Inc. (ALT). They have executed 92 insider transactions totaling $4.5M over their tenure at the company.
Mitchel Sayare holds the position of Executive at Altimmune, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mitchel Sayare has shown a selling trading pattern, with $171.7K in total purchases and $4.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mitchel Sayare was on Nov 5, 2009, when they sold $1.1M worth of IMGN shares. This transaction involved 150,000 shares at $7.38 per share.
Mitchel Sayare currently owns 34,900 shares of Altimmune, Inc. (ALT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mitchel Sayare's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mitchel Sayare has 92 Form 4 filings on record as an insider at Altimmune, Inc..
Set alerts for Mitchel Sayare and 40,000+ other insiders.